SCHEMBL7140197

SCHEMBL7140197

CC(C(=O)O)C1C2CCCC1CNC2

nearest known ligand 0.34

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 12/20 0.34
CHRNA4 P43681 12/20 0.34
CHRNB4 P30926 11/20 0.34
CHRNA3 P32297 11/20 0.34
CHRNA7 P36544 10/20 0.34
ACE P12821 1/20 0.33
GRM2 Q14416 1/20 0.32
CPN1 P15169 1/20 0.31
CPB2 Q96IY4 1/20 0.31
TSHR P16473 2/20 0.31
SLC6A1 P30531 2/20 0.31
SLC6A11 P48066 1/20 0.31
LMNA P02545 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
SLC6A13 Q9NSD5 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6745243 0.98 CHRNB2 (0.33) CHRNB2CHRNA4CHRNB4CHRNA3CHRNA7
SCHEMBL6745386 0.78 CHRNB2 (0.34) CHRNB2CHRNA4CHRNB4CHRNA3CHRNA7
SCHEMBL6749204 0.77 CPN1 (0.38) CHRNB2CHRNA4CHRNB4CHRNA3CHRNA7
SCHEMBL25355467 0.75 TSHR (0.34) CHRNB2CHRNA4CHRNB4CHRNA3CHRNA7
SCHEMBL25355474 0.75 TSHR (0.34) CHRNB2CHRNA4CHRNB4CHRNA3CHRNA7
Hydrochloric Acid SCHEMBL6745852 0.75 CPN1 (0.37) CHRNB2CHRNA4CHRNB4CHRNA3CHRNA7
SCHEMBL18118177 0.74 CCR5 (0.38) TSHR
Hydrochloric Acid SCHEMBL23581405 0.74 IDO1 (0.33) CHRNB2CHRNA4CHRNB4CHRNA3CHRNA7
Oxalic Acid SCHEMBL6747461 0.73 KDM4E (0.34) ACESMN1; SMN2
Hydrochloric Acid SCHEMBL342797 0.73 CHRNB2 (0.36) CHRNB2CHRNA4CHRNB4CHRNA3CHRNA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6518423-B1 These compounds are useful as drugs efficacious in the prevention and treatment of these various inflammatory diseases and immunologic diseases, such as rheumatoid arthritis, atopic dermatitis, psoriasis, asthma, and EISAI CO., LTD. (JP) 2003-02-11 US disclosed
EP-0934941-A1 BENZOPIPERIDINE DERIVATIVES Eisai Co., Ltd. (JP) 1999-08-11 EP disclosed